A detailed history of Becker Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Becker Capital Management Inc holds 304,445 shares of MRK stock, worth $30.3 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
304,445
Previous 315,532 3.51%
Holding current value
$30.3 Million
Previous $39.1 Million 11.49%
% of portfolio
1.14%
Previous 1.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$111.15 - $128.97 $1.23 Million - $1.43 Million
-11,087 Reduced 3.51%
304,445 $34.6 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $1.4 Million - $1.5 Million
-11,276 Reduced 3.45%
315,532 $39.1 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $1.1 Million - $1.29 Million
-9,745 Reduced 2.9%
326,808 $43.1 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $804,645 - $875,648
-8,032 Reduced 2.33%
336,553 $36.7 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $366,707 - $407,243
-3,562 Reduced 1.02%
344,585 $35.5 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $555,214 - $605,158
-5,112 Reduced 1.45%
348,147 $40.2 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $859,754 - $959,310
-8,352 Reduced 2.31%
353,259 $37.6 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $690,863 - $885,781
-7,901 Reduced 2.14%
361,611 $40.1 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $860,853 - $967,072
-10,184 Reduced 2.68%
369,512 $31.8 Million
Q2 2022

Aug 04, 2022

SELL
$83.49 - $94.64 $165,393 - $187,481
-1,981 Reduced 0.52%
379,696 $34.6 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $51,383 - $57,597
-699 Reduced 0.18%
381,677 $31.3 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $387,709 - $485,656
-5,364 Reduced 1.38%
382,376 $29.3 Million
Q3 2021

Oct 14, 2021

SELL
$71.68 - $78.83 $224,430 - $246,816
-3,131 Reduced 0.8%
387,740 $29.1 Million
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $243,624 - $269,473
-3,465 Reduced 0.88%
390,871 $30.4 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $744,789 - $877,285
10,816 Added 2.82%
394,336 $30.4 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $621,528 - $689,769
-8,660 Reduced 2.21%
383,520 $31.4 Million
Q3 2020

Nov 09, 2020

BUY
$73.18 - $82.95 $648,960 - $735,600
8,868 Added 2.31%
392,180 $32.5 Million
Q2 2020

Aug 11, 2020

SELL
$70.42 - $80.13 $2.62 Million - $2.98 Million
-37,172 Reduced 8.84%
383,312 $29.6 Million
Q1 2020

May 07, 2020

SELL
$63.36 - $87.82 $3.12 Million - $4.33 Million
-49,251 Reduced 10.48%
420,484 $32.4 Million
Q4 2019

Feb 11, 2020

SELL
$77.58 - $87.54 $2.81 Million - $3.17 Million
-36,262 Reduced 7.17%
469,735 $42.7 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $1.47 Million - $1.6 Million
-19,339 Reduced 3.68%
505,997 $42.6 Million
Q2 2019

Aug 08, 2019

SELL
$69.84 - $81.59 $2.55 Million - $2.98 Million
-36,567 Reduced 6.51%
525,336 $44 Million
Q1 2019

May 08, 2019

SELL
$69.58 - $79.36 $1.71 Million - $1.95 Million
-24,548 Reduced 4.19%
561,903 $46.7 Million
Q4 2018

Feb 04, 2019

SELL
$65.24 - $75.71 $14.3 Million - $16.6 Million
-219,551 Reduced 27.24%
586,451 $44.8 Million
Q3 2018

Nov 05, 2018

SELL
$57.69 - $67.84 $164,358 - $193,276
-2,849 Reduced 0.35%
806,002 $57.2 Million
Q2 2018

Aug 03, 2018

SELL
$50.83 - $59.72 $171,246 - $201,196
-3,369 Reduced 0.41%
808,851 $49.1 Million
Q1 2018

May 07, 2018

BUY
$50.96 - $59.23 $1.8 Million - $2.09 Million
35,242 Added 4.54%
812,220 $44.2 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $10.3 Million - $12.3 Million
199,315 Added 34.5%
776,978 $43.7 Million
Q3 2017

Nov 02, 2017

BUY
$58.67 - $63.13 $544,164 - $585,530
9,275 Added 1.63%
577,663 $37 Million
Q2 2017

Aug 11, 2017

BUY
N/A
568,388
568,388 $36.4 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Becker Capital Management Inc Portfolio

Follow Becker Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.